# Intrathecal Midazolam, Fentanyl and Nalbuphine as Adjuvants to Bupivacaine in Spinal Anesthesia for Cesarean Section

> **NCT04932083** · NA · COMPLETED · sponsor: **Benha University** · enrollment: 100 (actual)

## Conditions studied

- Pain, Acute

## Interventions

- **DRUG:** Bupivacaine
- **DRUG:** Fentanyl
- **DRUG:** Nalbuphine
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT04932083
- **Lead sponsor:** Benha University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-20
- **Primary completion:** 2022-01-14
- **Final completion:** 2022-02-24
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2022-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04932083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04932083, "Intrathecal Midazolam, Fentanyl and Nalbuphine as Adjuvants to Bupivacaine in Spinal Anesthesia for Cesarean Section". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04932083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*